Statistical design considerations for pilot studies transitioning therapies from the bench to the bedside

Journal of Translational Medicine

Volumn 2, Issue , 2004, Pages

  Carter, Rickey E ^a   Woolson, Robert F ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CISPLATIN;

ARTICLE; BINOMIAL DISTRIBUTION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG SAFETY; EMPIRICISM; HEARING LOSS; HEAT SHOCK; HUMAN; MATHEMATICAL ANALYSIS; MATHEMATICAL COMPUTING; MEDICAL ILLUSTRATION; OTOTOXICITY; PILOT STUDY; PROBABILITY; STATISTICAL ANALYSIS; TREATMENT PLANNING;

EID: 18144386952     PISSN: 14795876     EISSN: None     Source Type: Journal    
DOI: 10.1186/1479-5876-2-37     Document Type: Article

References (11)

1. Spilker B: Guide to Clinical Trials Raven Press; 1991.
2. Friedman LM, Furberg C, DeMets DL: Fundamentals of Clinical Trials Springer-Verlag Inc; 1998.
3. Schoenfeld D: Statistical considerations for pilot studies. International Journal of Radiation Oncology, Biology, Physics 1980, 6(3):371-374.
4. Shih WJ, Ohman-Strickland PA, Lin Y: Analysis of pilot and early phase studies with small sample sizes. Statistics in Medicine 2004, 23:1827-1842.
5. Clopper CJ, Pearson ES: The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 1934, 26:406-413.
6. Louis TA: Confidence intervals for a binomial parameter after observing no successes. The American Statistician 1981, 35:154-154.
7. Grau J, Estape J, Cuchi M, Firvida J, Blanch J, Ascaso C: Calcium supplementation and ototoxicity in patients receiving cisplatin. Br J Clin Pharmacol 1996, 42:233-235.
8. Kovach J, Moertel C, Schutt A, Reitemeier R, Hahn R: Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel. Cancer Chemother Rep 1973, 57(3):357-359.
9. Carter RE, Woolson RF: Safety Assessment in Pilot Studies When Zero Events Are Observed. Proceedings of International Conference On Statistics in Health Sciences in press.
10. Winkler RL, Smith JE, Fryback DG: The Role of Informative Priors in Zero-numerator Problems: Being Conservative Versus Being Candid. The American Statistician 2002, 56:1-4.
11. Lewis JA: Post-marketing surveillance - how many patients? Trends in Pharmacological Sciences 1981, 2:93-94.